Not Yet Recruiting
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
NCT06763302
- Conditions
- B Cell Precursor Acute Lymphoblastic Leukemia, Minimal Residual Disease, Neoplasm, Residual, +6 more
- Locations
-
Not specified